Cargando…
Colonization screening positivity rates for novel multidrug-resistant organism healthcare containment responses during 2019–2022
Background: The CDC recommends a public health response when novel and targeted multidrug-resistant organisms (nMDROs), such as carbapenem-resistant organisms or Candida auris, are identified in healthcare settings in nonendemic areas. nMDRO responses are supported by healthcare-associated infection...
Autores principales: | Rankin, Danielle, Ochoa, Lucas, Sanchez, Guillermo, Forsberg, Kaitlin, Lyman, Meghan, Shrivastwa, Nijika, Walters, Maroya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594283/ http://dx.doi.org/10.1017/ash.2023.373 |
Ejemplares similares
-
Outbreak response activities conducted by public health programs in healthcare facilities nationwide, August 2019–July 2020
por: Shrivastwa, Nijika, et al.
Publicado: (2022) -
Candida auris screening practices at healthcare facilities in the United States: A survey of the Emerging Infections Network
por: Hennessee, Ian, et al.
Publicado: (2023) -
An interactive patient transfer network and model visualization tool for multidrug-resistant organism prevention strategies
por: Octaria, Rany, et al.
Publicado: (2023) -
Healthcare-associated infections by multidrug-resistant bacteria in Andalusia, Spain, 2014 to 2021
por: Fernández-Martínez, Nicolás Francisco, et al.
Publicado: (2023) -
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023
por: Kissling, Esther, et al.
Publicado: (2023)